
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 100.680 | 100.680 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.879 | 19.929 |
Price to Book | 3.163 | 3.919 |
Price to Sales | 2.457 | 2.270 |
Price to Cash Flow | 13.044 | 15.391 |
Dividend Yield | 1.321 | 1.437 |
5 Years Earnings Growth | 16.668 | 10.972 |
Number of long holdings: 50
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Medincell | FR0004065605 | 6.32 | 15.45 | -1.15% | |
Eli Lilly | US5324571083 | 4.74 | 819.36 | +0.90% | |
UnitedHealth | US91324P1021 | 4.52 | 313.53 | -1.56% | |
Boston Scientific | US1011371077 | 3.42 | 99.74 | +1.20% | |
AstraZeneca | GB0009895292 | 3.36 | 10,986.0 | -0.40% | |
Becton Dickinson | US0758871091 | 3.26 | 172.21 | -1.29% | |
RaySearch Labs B | SE0000135485 | 3.16 | 306.50 | -3.46% | |
Fresenius SE | DE0005785604 | 3.13 | 44.000 | -0.54% | |
Lantheus Holdings Inc | US5165441032 | 2.82 | 77.83 | -2.88% | |
Sanofi | FR0000120578 | 2.79 | 86.80 | -1.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pluvalca Disruptive Opportunities A | 108.51M | 2.70 | -3.47 | - | ||
Pluvalca Initiatives PME A | 80.56M | 16.90 | -2.04 | 7.06 | ||
Pluvalca France Small Caps A | 61.42M | 11.84 | 0.10 | 3.99 | ||
Pluvalca Allcaps A | 53.72M | 8.96 | 5.20 | 4.95 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review